BOESS CARSTEN

Vice President, International at INSULET CORP · on record since Mar 3, 2010
SVP, Chief Financial Officer at TRIMERIS INC · on record since Jun 29, 2012
Director at ROCKET PHARMACEUTICALS, INC. · on record since Jan 12, 2016
10% owner at Kiniksa Pharmaceuticals International, plc · on record since May 29, 2018
Vice President & CFO at ALEXION PHARMACEUTICALS INC · on record since Mar 11, 2005
Director at Orchestra BioMed Holdings, Inc. · on record since Aug 10, 2020
Former CFO at ALEXION PHARMACEUTICALS INC · on record since Jun 29, 2005
Director at Avidity Biosciences, Inc. · on record since Jun 11, 2020

Insider trading activity of BOESS CARSTEN

Transactions on record: 230; since Jun 29, 2005

Open-market buys: 1; $117.8K

Open-market sells: 116; $18.1M

Companies traded: 7; last filing Jul 6, 2026

Figures computed from official regulatory filings — .

Companies where BOESS CARSTEN has traded

ROCKET PHARMACEUTICALS, INC.13 tx · Jul 6, 2026
Atrium Therapeutics, Inc.1 tx · Mar 2, 2026
Avidity Biosciences, Inc.13 tx · Feb 27, 2026
Kiniksa Pharmaceuticals International, plc5 tx · $100K · May 29, 2018
TRIMERIS INC77 tx · $14.8M · Jun 23, 2015
INSULET CORP118 tx · $6.8M · Apr 27, 2011
ALEXION PHARMACEUTICALS INC3 tx · $409K · Jun 29, 2005

Track record of BOESS CARSTEN

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of BOESS CARSTEN

Co-insiders of BOESS CARSTEN

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
ROCKET PHARMACEUTICALS, INC.	Jul 6, 2026	AwardD (derivative)	64,860	0.00 USD	—	SEC
ROCKET PHARMACEUTICALS, INC.	Jul 6, 2026	Award	22,862	0.00 USD	—	SEC
Atrium Therapeutics, Inc.	Mar 2, 2026	AwardD (derivative)	20,000	0.00 USD	—	SEC
Avidity Biosciences, Inc.	Feb 27, 2026	Other	-6,692	—	—	SEC
Avidity Biosciences, Inc.	Feb 27, 2026	OtherD (derivative)	-22,000	—	—	SEC
Avidity Biosciences, Inc.	Feb 27, 2026	OtherD (derivative)	-10,034	—	—	SEC
Avidity Biosciences, Inc.	Feb 27, 2026	OtherD (derivative)	-20,858	—	—	SEC
Avidity Biosciences, Inc.	Feb 27, 2026	OtherD (derivative)	-22,000	—	—	SEC
Avidity Biosciences, Inc.	Feb 27, 2026	OtherD (derivative)	-15,000	—	—	SEC
Avidity Biosciences, Inc.	Feb 27, 2026	OtherD (derivative)	-13,489	—	—	SEC
ROCKET PHARMACEUTICALS, INC.	Jul 18, 2025	Award	30,000	0.00 USD	—	SEC
Avidity Biosciences, Inc.	Jun 12, 2025	Award	6,692	0.00 USD	—	SEC
Avidity Biosciences, Inc.	Jun 12, 2025	AwardD (derivative)	10,034	0.00 USD	—	SEC
ROCKET PHARMACEUTICALS, INC.	Jun 20, 2024	AwardD (derivative)	23,944	0.00 USD	—	SEC
Avidity Biosciences, Inc.	Jun 14, 2024	AwardD (derivative)	13,489	0.00 USD	—	SEC
ROCKET PHARMACEUTICALS, INC.	Jun 26, 2023	AwardD (derivative)	25,850	0.00 USD	—	SEC
Avidity Biosciences, Inc.	Jun 20, 2023	AwardD (derivative)	22,000	0.00 USD	—	SEC
Avidity Biosciences, Inc.	Jun 17, 2022	AwardD (derivative)	22,000	0.00 USD	—	SEC
ROCKET PHARMACEUTICALS, INC.	Jun 15, 2022	AwardD (derivative)	47,745	0.00 USD	—	SEC
Avidity Biosciences, Inc.	Jun 16, 2021	AwardD (derivative)	15,000	0.00 USD	—	SEC
ROCKET PHARMACEUTICALS, INC.	Jun 16, 2021	AwardD (derivative)	12,236	0.00 USD	—	SEC
ROCKET PHARMACEUTICALS, INC.	Jun 18, 2020	AwardD (derivative)	20,000	0.00 USD	—	SEC
ROCKET PHARMACEUTICALS, INC.	Jan 30, 2019	AwardD (derivative)	30,000	0.00 USD	—	SEC
Kiniksa Pharmaceuticals International, plc	May 29, 2018	OtherD (derivative)	-6,392	0.00 USD	—	SEC
Kiniksa Pharmaceuticals International, plc	May 29, 2018	Other	6,392	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
ROCKET PHARMACEUTICALS, INC.	Jul 6, 2026	AwardD (derivative)	64,860	0.00 USD	—	SEC
ROCKET PHARMACEUTICALS, INC.	Jul 6, 2026	Award	22,862	0.00 USD	—	SEC
Atrium Therapeutics, Inc.	Mar 2, 2026	AwardD (derivative)	20,000	0.00 USD	—	SEC
Avidity Biosciences, Inc.	Feb 27, 2026	Other	-6,692	—	—	SEC
Avidity Biosciences, Inc.	Feb 27, 2026	OtherD (derivative)	-22,000	—	—	SEC
Avidity Biosciences, Inc.	Feb 27, 2026	OtherD (derivative)	-10,034	—	—	SEC
Avidity Biosciences, Inc.	Feb 27, 2026	OtherD (derivative)	-20,858	—	—	SEC
Avidity Biosciences, Inc.	Feb 27, 2026	OtherD (derivative)	-22,000	—	—	SEC
Avidity Biosciences, Inc.	Feb 27, 2026	OtherD (derivative)	-15,000	—	—	SEC
Avidity Biosciences, Inc.	Feb 27, 2026	OtherD (derivative)	-13,489	—	—	SEC
ROCKET PHARMACEUTICALS, INC.	Jul 18, 2025	Award	30,000	0.00 USD	—	SEC
Avidity Biosciences, Inc.	Jun 12, 2025	Award	6,692	0.00 USD	—	SEC
Avidity Biosciences, Inc.	Jun 12, 2025	AwardD (derivative)	10,034	0.00 USD	—	SEC
ROCKET PHARMACEUTICALS, INC.	Jun 20, 2024	AwardD (derivative)	23,944	0.00 USD	—	SEC
Avidity Biosciences, Inc.	Jun 14, 2024	AwardD (derivative)	13,489	0.00 USD	—	SEC
ROCKET PHARMACEUTICALS, INC.	Jun 26, 2023	AwardD (derivative)	25,850	0.00 USD	—	SEC
Avidity Biosciences, Inc.	Jun 20, 2023	AwardD (derivative)	22,000	0.00 USD	—	SEC
Avidity Biosciences, Inc.	Jun 17, 2022	AwardD (derivative)	22,000	0.00 USD	—	SEC
ROCKET PHARMACEUTICALS, INC.	Jun 15, 2022	AwardD (derivative)	47,745	0.00 USD	—	SEC
Avidity Biosciences, Inc.	Jun 16, 2021	AwardD (derivative)	15,000	0.00 USD	—	SEC
ROCKET PHARMACEUTICALS, INC.	Jun 16, 2021	AwardD (derivative)	12,236	0.00 USD	—	SEC
ROCKET PHARMACEUTICALS, INC.	Jun 18, 2020	AwardD (derivative)	20,000	0.00 USD	—	SEC
ROCKET PHARMACEUTICALS, INC.	Jan 30, 2019	AwardD (derivative)	30,000	0.00 USD	—	SEC
Kiniksa Pharmaceuticals International, plc	May 29, 2018	OtherD (derivative)	-6,392	0.00 USD	—	SEC
Kiniksa Pharmaceuticals International, plc	May 29, 2018	Other	6,392	0.00 USD	—	SEC